DK1795183T3 - Vandige dispersioner og oplösninger af vanskeligt oplöselige forbindelser og fremgangsmåder til deres fremstilling - Google Patents

Vandige dispersioner og oplösninger af vanskeligt oplöselige forbindelser og fremgangsmåder til deres fremstilling

Info

Publication number
DK1795183T3
DK1795183T3 DK06252582T DK06252582T DK1795183T3 DK 1795183 T3 DK1795183 T3 DK 1795183T3 DK 06252582 T DK06252582 T DK 06252582T DK 06252582 T DK06252582 T DK 06252582T DK 1795183 T3 DK1795183 T3 DK 1795183T3
Authority
DK
Denmark
Prior art keywords
solutions
processes
preparation
aqueous dispersions
poorly soluble
Prior art date
Application number
DK06252582T
Other languages
English (en)
Inventor
Yosef Bershteyn
Anna Faingersh
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of DK1795183T3 publication Critical patent/DK1795183T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK06252582T 2005-12-09 2006-05-12 Vandige dispersioner og oplösninger af vanskeligt oplöselige forbindelser og fremgangsmåder til deres fremstilling DK1795183T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74924405P 2005-12-09 2005-12-09

Publications (1)

Publication Number Publication Date
DK1795183T3 true DK1795183T3 (da) 2009-10-19

Family

ID=36950167

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06252582T DK1795183T3 (da) 2005-12-09 2006-05-12 Vandige dispersioner og oplösninger af vanskeligt oplöselige forbindelser og fremgangsmåder til deres fremstilling

Country Status (11)

Country Link
US (1) US8470344B2 (da)
EP (1) EP1795183B1 (da)
JP (1) JP2009518395A (da)
CA (1) CA2630304C (da)
DE (1) DE602006007790D1 (da)
DK (1) DK1795183T3 (da)
ES (1) ES2327775T3 (da)
IL (1) IL191524A (da)
PL (1) PL1795183T3 (da)
PT (1) PT1795183E (da)
WO (1) WO2007067208A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
EP2214679B1 (en) 2007-11-13 2019-03-27 Meritage Pharma, Inc. Corticosteroid compositions
US20090143343A1 (en) 2007-11-13 2009-06-04 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
GR20090100230A (el) 2009-04-14 2010-11-18 Casso Pharmaceuticals Ε.Π.Ε, Απο του στοματος εναιωρημα οξικης δεξαμεθανοζης-συνθεση καλυψης γευσης της δεξαμεθανοζης
EP2269575A1 (en) * 2009-06-30 2011-01-05 Santen Pharmaceutical Co., Ltd Method for improving bioavailability of latanoprost
EP2522374B1 (en) * 2009-12-28 2015-08-19 Kawasumi Laboratories, Inc. Anti-adhesion material
US9782731B2 (en) 2014-05-30 2017-10-10 Battelle Memorial Institute System and process for dissolution of solids
CN108376492B (zh) * 2018-03-16 2020-10-02 成都博士信智能科技发展有限公司 交通器模拟方法及系统
CN113295678B (zh) * 2021-05-14 2022-11-08 济南迪曼生物科技有限公司 一种电化学发光清洗液

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616672D0 (en) * 1996-08-08 1996-09-25 Scherer Ltd R P Pharmaceutical compositions
US6077543A (en) * 1996-12-31 2000-06-20 Inhale Therapeutic Systems Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
EP1348432A4 (en) * 2001-01-04 2005-08-10 Daiichi Seiyaku Co CYCLODEXTRIN-CONTAINING PHARMACEUTICAL COMPOSITION
DE60100389T2 (de) * 2001-07-11 2004-05-19 Apr Applied Pharma Research S.A. Fettlösliche Substanzen enthaltende Granulate und Verfahren zu ihrer Herstellung
US7815936B2 (en) * 2001-10-30 2010-10-19 Evonik Degussa Gmbh Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
WO2003063835A1 (en) * 2002-01-28 2003-08-07 Phares Pharmaceutical Research N.V. Composition comprising low water soluble compounds within porous carriers
JP2003342168A (ja) * 2002-05-24 2003-12-03 Nano Career Kk 注射用薬物含有ポリマーミセル製剤の製造方法
DK1532981T3 (da) * 2002-08-23 2008-01-28 Santen Pharmaceutical Co Ltd Stabile öjendråber, der indeholder latanoprost som den aktive bestanddel
WO2004075817A2 (en) * 2003-02-26 2004-09-10 Vrije Universiteit Brussel Suspendable pharmaceutical composition

Also Published As

Publication number Publication date
US20070134278A1 (en) 2007-06-14
EP1795183B1 (en) 2009-07-15
CA2630304A1 (en) 2007-06-14
IL191524A (en) 2013-04-30
DE602006007790D1 (de) 2009-08-27
CA2630304C (en) 2012-04-10
JP2009518395A (ja) 2009-05-07
WO2007067208A1 (en) 2007-06-14
IL191524A0 (en) 2008-12-29
PL1795183T3 (pl) 2009-12-31
ES2327775T3 (es) 2009-11-03
US8470344B2 (en) 2013-06-25
PT1795183E (pt) 2009-08-21
EP1795183A1 (en) 2007-06-13

Similar Documents

Publication Publication Date Title
DK1981863T3 (da) Fremgangsmåde til fremstilling af aminocrotonylaminosubtituerede quinazolinderivater
DK2229360T3 (da) Indolinonderivater og fremgangsmåde til deres fremstilling
DK1893586T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler
DK2048941T3 (da) Fremgangsmåde til opdræt af rovmider
DK2086944T3 (da) Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater
DK2358691T3 (da) Fremgangsmåde til fremstilling af piperazinforbindelser og hydrochloridsalte deraf
NO20085030L (no) Pyrrolopyrimidinforbindelser og deres anvendelser
DK1896065T4 (da) Fremgangsmåde til fremstilling af vacciner
DK1877232T3 (da) Fremgangsmåde til behandling af træoverflader
NO20091423L (no) Pyrimidinderivater og deres anvendelse som kinaseinhibitorer
DK2183263T3 (da) Fremgangsmåder og forbindelser anvendelige til fremstilling af natriumglucose-cotransportør-2-inhibitorer
DK2431359T3 (da) Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser
DK2032598T3 (da) Axmi-031, axmi-039, axmi-040 og axmi-049, en familie af deltaendotoksingener og fremgangsmåder til deres anvendelse
DK2089361T5 (da) Inhibitorer af natriumglucose-cotransportør 2 og fremgangsmåder til deres anvendelse
DK1945631T3 (da) 4- (3-aminopyrazole) pyrimidinderivater til anvendelse som tyrosinkinaseinhibitorer til behandling af cancer
DK1888294T3 (da) Fremgangsmåde til hårdlodning af artikler af rustfrit stål
DK3081215T3 (da) Sammensætninger og fremgangsmåder til langvarig frigørelse af beta-alanin
DK2470520T3 (da) Chromonderivater, fremgangsmåde til fremstilling af disse og deres terapeutiske anvendelser
DK1813678T3 (da) Fremgangsmåde til fremstilling af glycogen
DK2213654T3 (da) Fremgangsmåde til fremstilling af 2-amino-5-brombenzamid derivater
DK1745136T3 (da) Fremgangsmåde til enzymatisk fremstilling af (S)-3-cyano-5-methylhexansyre
DK1948754T3 (da) Sammensætning og fremgangsmåde til fortykkelse af tunge, vandige saltopløsninger
DK2192117T3 (da) Organisk aminsalt af 6-fluor-3-hydroxy-2-pyrazincarbonitril og fremgangsmåde til fremstilling deraf
DK2215050T3 (da) Fremgangsmåde til fremstilling af 2-hydroxy-5-phenylalkylaminobenzoesyrederivater og salte deraf
DK2041069T3 (da) Benzylaminer, fremgangsmåde til fremstilling deraf og deres anvendelse som anti-inflammatoriske midler